Shawn Zheng Kai Tan, Joshua Daniel Valdez, Saritha Vettikunnel Kuriakose
{"title":"Navigating open-source waters: the pharmaceutical industry's role in bioontology development.","authors":"Shawn Zheng Kai Tan, Joshua Daniel Valdez, Saritha Vettikunnel Kuriakose","doi":"10.1093/database/baaf066","DOIUrl":null,"url":null,"abstract":"<p><p>Bioontologies are core to many data management strategies, artificial intelligence and machine learning initiatives, and search functionality within many pharmaceutical companies. Despite their integral role, many bioontologies, along with their associated tools, are maintained predominantly by academia and their partners, government supported initiatives, and the general community. In this comment, we will dive into some of the reasons behind this trend and argue that there exists a mutual advantage for the life science industry, and pharmaceutical companies in particular, to actively contribute to the advancement of public ontologies and open-source tools. This benefit extends beyond ethical and moral considerations and aligns with strategic interests. Additionally, we will explore practical approaches for contributing, sharing our (Novo Nordisk's research and early development) experience in doing so.</p>","PeriodicalId":10923,"journal":{"name":"Database: The Journal of Biological Databases and Curation","volume":"2025 ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482910/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Database: The Journal of Biological Databases and Curation","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/database/baaf066","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Bioontologies are core to many data management strategies, artificial intelligence and machine learning initiatives, and search functionality within many pharmaceutical companies. Despite their integral role, many bioontologies, along with their associated tools, are maintained predominantly by academia and their partners, government supported initiatives, and the general community. In this comment, we will dive into some of the reasons behind this trend and argue that there exists a mutual advantage for the life science industry, and pharmaceutical companies in particular, to actively contribute to the advancement of public ontologies and open-source tools. This benefit extends beyond ethical and moral considerations and aligns with strategic interests. Additionally, we will explore practical approaches for contributing, sharing our (Novo Nordisk's research and early development) experience in doing so.
期刊介绍：
Huge volumes of primary data are archived in numerous open-access databases, and with new generation technologies becoming more common in laboratories, large datasets will become even more prevalent. The archiving, curation, analysis and interpretation of all of these data are a challenge. Database development and biocuration are at the forefront of the endeavor to make sense of this mounting deluge of data.
Database: The Journal of Biological Databases and Curation provides an open access platform for the presentation of novel ideas in database research and biocuration, and aims to help strengthen the bridge between database developers, curators, and users.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
